Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.49 |
| ▸ | KDM1A | O60341 | 2/20 | 0.40 |
| ▸ | BACE1 | P56817 | 15/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | CTSD | P07339 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7918070 | 0.82 | BACE1 (0.40) | TAAR1ADRA2ABACE1CTSDCTSB | |
| SCHEMBL7919559 | 0.80 | TAAR1 (0.52) | TAAR1ADRA2ABACE1 | |
| SCHEMBL7916183 | 0.80 | TAAR1 (0.52) | TAAR1ADRA2ABACE1 | |
| SCHEMBL7922745 | 0.80 | TAAR1 (0.52) | TAAR1ADRA2ABACE1 | |
| SCHEMBL7918392 | 0.77 | TAAR1 (0.52) | TAAR1ADRA2ABACE1CTSD | |
| SCHEMBL7923456 | 0.76 | TAAR1 (0.57) | TAAR1ADRA2ABACE1CTSDCTSB | |
| SCHEMBL7922742 | 0.76 | TAAR1 (0.48) | TAAR1ADRA2ABACE1CTSD | |
| SCHEMBL7925662 | 0.76 | TAAR1 (0.60) | TAAR1ADRA2ABACE1CTSDCTSB | |
| SCHEMBL7926209 | 0.75 | BACE1 (0.53) | TAAR1ADRA2ABACE1CTSD | |
| SCHEMBL7924073 | 0.75 | BACE1 (0.53) | TAAR1ADRA2ABACE1CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010042475-A1 | SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS | SCHERING CORPORATION (US) | 2010-04-15 | — | — | WO | disclosed |